MAPK9 and breast cancer: In our previous studies, LINC00958 has been found to promote BC cell growth and epithelial-mesenchymal transition via inhibiting the SAPK/JNK axis [5], but the downstream target genes involved in changes in BC cell behavior regulated by LINC00958 remain unclear.